Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 366

1.

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.

Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C; Hep-Net B/C Co-infection Study Group.

J Hepatol. 2008 Nov;49(5):688-94. doi: 10.1016/j.jhep.2008.03.028. Epub 2008 Apr 29.

PMID:
18490077
[PubMed - indexed for MEDLINE]
2.

Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.

Senturk H, Tahan V, Canbakan B, Uraz S, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G.

Neth J Med. 2008 May;66(5):191-5.

PMID:
18490796
[PubMed - indexed for MEDLINE]
Free Article
3.

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.

Chen LW, Chien RN, Yen CL, Chang JJ, Liu CJ, Lin CL.

J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.

PMID:
19817959
[PubMed - indexed for MEDLINE]
4.

Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.

Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.

Antivir Ther. 2005;10(1):125-33.

PMID:
15751770
[PubMed - indexed for MEDLINE]
5.

Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C.

Pérez R, Jiménez M, Crespo J, Diago M, Enríquez J, Vaquero P, Solá R, Olcoz JL, Romero M, Salmerón J, Blanco MI, Oña M, Melón S, Rodrigo L; Grupo Inter-Hospitalario Español.

J Viral Hepat. 2003 Nov;10(6):437-45.

PMID:
14633177
[PubMed - indexed for MEDLINE]
6.

Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.

Khattab E, Chemin I, Vuillermoz I, Vieux C, Mrani S, Guillaud O, Trepo C, Zoulim F.

J Clin Virol. 2005 Jun;33(2):150-7. Epub 2004 Dec 18.

PMID:
15911431
[PubMed - indexed for MEDLINE]
7.

Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.

Potthoff A, Deterding K, Trautwein C, Rifai K, Manns MP, Wedemeyer H.

Eur J Gastroenterol Hepatol. 2007 Oct;19(10):906-9.

PMID:
17873617
[PubMed - indexed for MEDLINE]
8.

[Treatment of chronic hepatitis C with PEG-interferon alpha-2b and ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3].

Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns MP.

Z Gastroenterol. 2003 Jun;41(6):517-22. German.

PMID:
12806536
[PubMed - indexed for MEDLINE]
9.

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

Ferraro D, Bonura C, Giglio M, Di Stefano R, Almasio PL, Di Marco V, Craxì A, Cacciola I, Squadrito G, Raimondo G.

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.

PMID:
14518718
[PubMed - indexed for MEDLINE]
10.

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

Crespo M, Mira JA, Pineda JA, Van den Eynde E, Ríos-Villegas MJ, Collado A, Girón-González JA, López-Cortés LF, González-Serrano M, Rivero A, Merino D, Esteban JI.

J Antimicrob Chemother. 2008 Oct;62(4):793-6. doi: 10.1093/jac/dkn262. Epub 2008 Jun 21.

PMID:
18567911
[PubMed - indexed for MEDLINE]
Free Article
11.

Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.

Roffi L, Colloredo G, Pioltelli P, Bellati G, Pozzpi M, Parravicini P, Bellia V, Del Poggio P, Fornaciari G, Ceriani R, Ramella G, Corradi C, Rossini A, Bruno S; Gruppo Epatologico Lombardo.

Antivir Ther. 2008;13(5):663-73.

PMID:
18771050
[PubMed - indexed for MEDLINE]
12.

Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.

Derbala M, Amer A, Bener A, Lopez AC, Omar M, El Ghannam M.

J Viral Hepat. 2005 Jul;12(4):380-5.

PMID:
15985008
[PubMed - indexed for MEDLINE]
13.

[Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].

Pár A, Tornai I, Szalay F.

Orv Hetil. 2007 May 6;148(18):819-26. Hungarian.

PMID:
17468063
[PubMed - indexed for MEDLINE]
14.

Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.

Hung CH, Lee CM, Lu SN, Wang JH, Tung HD, Chen CH, Changchien CS.

J Gastroenterol Hepatol. 2005 May;20(5):727-32.

PMID:
15853986
[PubMed - indexed for MEDLINE]
15.

Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy.

Saitta C, Pontisso P, Brunetto MR, Fargion S, Gaeta GB, Niro GA, Picciotto A, Smedile A, Squadrito G, Raimondo G.

Antivir Ther. 2006;11(7):931-4.

PMID:
17302256
[PubMed - indexed for MEDLINE]
16.

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, Lin CL, Jeng YM, Chen PJ, Chen DS.

Gastroenterology. 2009 Feb;136(2):496-504.e3. doi: 10.1053/j.gastro.2008.10.049. Epub 2008 Oct 29.

PMID:
19084016
[PubMed - indexed for MEDLINE]
17.

[Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics].

Husa P, Slesinger P, Stroblová H, Svobodník A, Husová L.

Klin Mikrobiol Infekc Lek. 2008 Apr;14(2):67-73. Czech.

PMID:
18756436
[PubMed - indexed for MEDLINE]
18.

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.

Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study Group.

Gastroenterology. 2009 May;136(5):1618-28.e2. doi: 10.1053/j.gastro.2009.01.039. Epub 2009 Jan 22.

PMID:
19208349
[PubMed - indexed for MEDLINE]
19.

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

Piroth L, Carrat F, Larrat S, Goderel I, Martha B, Payan C, Lunel-Fabiani F, Bani-Sadr F, Perronne C, Cacoub P, Pol S, Morand P.

J Hepatol. 2008 Dec;49(6):892-8. doi: 10.1016/j.jhep.2008.06.024. Epub 2008 Jul 17.

PMID:
18752863
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection.

Jara P, Hierro L, de la Vega A, Díaz C, Camarena C, Frauca E, Miños-Bartolo G, Díez-Dorado R, de Guevara CL, Larrauri J, Rueda M.

Pediatr Infect Dis J. 2008 Feb;27(2):142-8. doi: 10.1097/INF.0b013e318159836c.

PMID:
18174875
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk